share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

辉瑞 | 4：持股变动声明-高管 BOURLA ALBERT
美股sec公告 ·  05/01 15:42
Moomoo AI 已提取核心信息
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on April 30, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, were not disclosed in the announcement. Following the action, the updated number of shares held by Bourla was not provided. This transaction is part of the regular financial disclosures made by company executives, which are closely monitored by investors for insights into executive confidence and company performance.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on April 30, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, were not disclosed in the announcement. Following the action, the updated number of shares held by Bourla was not provided. This transaction is part of the regular financial disclosures made by company executives, which are closely monitored by investors for insights into executive confidence and company performance.
辉瑞公司（PFE）董事长兼首席执行官阿尔伯特·布尔拉于2024年4月30日执行了一笔非衍生证券交易。公告中未披露该交易的具体细节，包括股票数量、交易价格和总价值。采取行动后，没有提供Bourla持有的最新股票数量。该交易是公司高管定期披露财务信息的一部分，投资者密切关注这些披露，以深入了解高管信心和公司业绩。
辉瑞公司（PFE）董事长兼首席执行官阿尔伯特·布尔拉于2024年4月30日执行了一笔非衍生证券交易。公告中未披露该交易的具体细节，包括股票数量、交易价格和总价值。采取行动后，没有提供Bourla持有的最新股票数量。该交易是公司高管定期披露财务信息的一部分，投资者密切关注这些披露，以深入了解高管信心和公司业绩。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息